by admin | Oct 16, 2023 | Pharma
MUMBAI: An indigenously developed therapy for treatment of relapsed/refractory B-cell lymphomas and leukaemia by an IIT-Bombay spin-off company has received approval from the national regulatory body and will be available in at least 20 major hospitals in the country,...